Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUbsetfusmca Regulatory News (UMC)

Share Price Information for Ubsetfusmca (UMC)

Share Price is delayed by 15 minutes
Get Live Data
697.20    0.00 (0.00%)
Bid:
692.10
Ask:
693.10
Spread: 1.00 (0.144%)
Market Cap: -
UMC Live PriceLast checked at - London Stock Exchange

Intraday Ubsetfusmca Share Chart

Form 8.3 - UMECO PLC

19 Jul 2012 10:31

RNS Number : 0432I
ODDO Asset Management
19 July 2012
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Oddo Asset Management

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

UMECO PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

18/07/2012

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

 

Class of relevant security:

Ordinary shares

1p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(2) Derivatives (other than options):CFD

1 136 634.00

2.34%

(3) Options and agreements to purchase/sell:

 

TOTAL:

1 136 634.00

2.34%

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

25p ordinary

CFD

increasing a long position

 400,000.00

548.82488

25p ordinary

CFD

increasing a long position

 500,000.00

548.9941

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

19/07/2012

Contact name:

Sophie SABRI

Telephone number:

+33 1 44 51 85 20

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETFMGMNLLGGZZG
Date   Source Headline
5th Jun 202610:18 amRNSNet Asset Value(s)
4th Jun 202610:16 amRNSNet Asset Value(s)
3rd Jun 202610:29 amRNSNet Asset Value(s)
2nd Jun 20262:51 pmRNSNet Asset Value(s)
1st Jun 202610:33 amRNSNet Asset Value(s)
29th May 202610:53 amRNSNet Asset Value(s)
28th May 202610:03 amRNSNet Asset Value(s)
27th May 202610:39 amRNSNet Asset Value(s)
26th May 20267:00 amRNSNet Asset Value(s)
22nd May 202610:28 amRNSNet Asset Value(s)
21st May 202610:04 amRNSNet Asset Value(s)
20th May 202610:15 amRNSNet Asset Value(s)
19th May 202610:09 amRNSNet Asset Value(s)
18th May 202610:13 amRNSNet Asset Value(s)
15th May 202610:26 amRNSNet Asset Value(s)
14th May 202610:38 amRNSNet Asset Value(s)
13th May 202610:06 amRNSNet Asset Value(s)
12th May 202611:23 amRNSNet Asset Value(s)
11th May 202612:02 pmRNSNet Asset Value(s)
8th May 202610:58 amRNSNet Asset Value(s)
7th May 202610:48 amRNSNet Asset Value(s)
6th May 202610:37 amRNSNet Asset Value(s)
5th May 202610:42 amRNSNet Asset Value(s)
5th May 20267:00 amRNSNet Asset Value(s)
1st May 202610:28 amRNSNet Asset Value(s)
30th Apr 202610:33 amRNSNet Asset Value(s)
29th Apr 202610:26 amRNSNet Asset Value(s)
28th Apr 202610:44 amRNSNet Asset Value(s)
27th Apr 202610:28 amRNSNet Asset Value(s)
24th Apr 202610:25 amRNSNet Asset Value(s)
23rd Apr 202610:25 amRNSNet Asset Value(s)
22nd Apr 202610:36 amRNSNet Asset Value(s)
21st Apr 202610:41 amRNSNet Asset Value(s)
20th Apr 202610:30 amRNSNet Asset Value(s)
17th Apr 202610:05 amRNSNet Asset Value(s)
16th Apr 202610:44 amRNSNet Asset Value(s)
15th Apr 202610:18 amRNSNet Asset Value(s)
14th Apr 202610:46 amRNSNet Asset Value(s)
13th Apr 202610:39 amRNSNet Asset Value(s)
10th Apr 202610:11 amRNSNet Asset Value(s)
9th Apr 202610:28 amRNSNet Asset Value(s)
8th Apr 202610:16 amRNSNet Asset Value(s)
7th Apr 202611:04 amRNSNet Asset Value(s)
1st Apr 202610:38 amRNSNet Asset Value(s)
31st Mar 202611:08 amRNSNet Asset Value(s)
30th Mar 202610:40 amRNSNet Asset Value(s)
27th Mar 202611:50 amRNSNet Asset Value(s)
26th Mar 202611:05 amRNSNet Asset Value(s)
25th Mar 202611:40 amRNSNet Asset Value(s)
24th Mar 202610:58 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.